Intrinsic RNA-targeting activity limits the applicability of CRISPR-Cas13.
Nature biomedical engineering, 8(2): 116-117 PMID 37903903 DOI 10.1038/s41551-023-01124-z
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.